DGX Stock Analysis: Buy, Sell, or Hold?
DGX - Quest Diagnostics Inc.
$231.95
-1.06 (-0.45%)
▼
5d:
+0.05%
30d:
+7.52%
90d:
+20.39%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 20, 2026
Get Alerted When DGX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: DGX is fairly valued with market pricing in 3.3% annual growth. Fine to hold or accumulate slowly on dips.
📊 HOLD: DGX is fairly valued with market pricing in 3.3% annual growth. Fine to hold or accumulate slowly on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$280.28
Based on 5.9% avg growth
INTRINSIC VALUE TODAY
$174.03
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 17.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: DGX is currently trading at $231.95, which is considered extended relative to its 30-day fair value range of $201.80 to $221.19. The stock's valuation (Forward PE: 19.2) is in line with its historical norms (17.5). At these levels, the market is pricing in 3.3% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, DGX is in a uptrend. Immediate support is located at $204.10, while resistance sits at $240.13.
Market Sentiment: DGX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, DGX is in a uptrend. Immediate support is located at $204.10, while resistance sits at $240.13.
Market Sentiment: DGX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$201.80 -
$221.19
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding DGX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($245.87)
- NEUTRAL: Market pricing in 3.3% annual earnings growth - fairly valued
Trading Range Analysis
30-Day Trading Range
$201.80 -
$221.19
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$204.10
Resistance Level
$240.13
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
19.24
Wall Street Target
$245.87
(+6.0%)
Revenue Growth (YoY)
10.2%
Earnings Growth (YoY)
15.0%
Profit Margin
9.2%
Valuation Premium vs History
+3.3% premium
PE vs Historical
19.2 vs 17.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.3%
(market-implied from PE analysis)
1-Year Target
$239.60
(+3%)
2-Year Target
$247.51
(+7%)
3-Year Target
$255.68
(+10%)
3-Yr Target (if PE normalizes)
(PE: 19→18)
PE COMPRESSION
$232.60
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 7.7%)
$312.58
(+35%)
Base:
(SPY PE: 19.2, Growth: 7.7%)
$290.06
(+25%)
Bear:
(PE: 16.4, Growth: 7.7%)
$246.55
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (19x PE) as earnings recover.
Trailing PE: 24.76 | Current EPS (TTM): $9.41
Bull Case
$328.43
(+42%)
Analyst growth 28.1%, PE expands to 27.2
Base Case
$298.57
(+29%)
Market implied 28.1%, PE stable at 24.8
Bear Case
$158.45
(-32%)
Severe decline -20.0%, PE contracts to 21.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 04, 2026 5:42 AM ET
Data refreshes hourly during market hours. Next update: 6:42 AM
Data refreshes hourly during market hours. Next update: 6:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DGX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
9
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael E Prevoznik
SELL
3878 shares
2026-03-05
Patrick Plewman
SELL
2855 shares
2026-03-05
Catherine T Doherty
SELL
5558 shares
2026-03-05
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$630 | 53 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$188 | 61 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$228 | 52 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$283 | 59 HOLD |
Advanced DGX Option Strategies
Professional options setups generated by AI based on today's DGX price and gamma walls.
